Stockreport

Ocuphire Pharma Announces Presentations on the Development of APX3330 for Diabetic Retinopathy at Retina Meetings in June [Yahoo! Finance]

Ocuphire Pharma, Inc.  (OCUP) 
PDF company focused on developing small molecule therapies for the treatment of patients with retinal and refractive eye disorders, today announced that clinical updates on [Read more]